Decreased cardiac activity of AMP deaminase in subjects with the AMPD1 mutation--a potential mechanism of protection in heart failure.
暂无分享,去创建一个
M. Yacoub | K. Kalsi | E. Birks | E. Slominska | R. Smolenski | Philip H. Johnson | A. Yuen | K. Kaletha | I. Rybakowska
[1] D. Janero,et al. Mammalian-heart adenylate deaminase: Cross-species immunoanalysis of tissue distribution with a cardiac-directed antibody , 1995, Molecular and Cellular Biochemistry.
[2] I. Biaggioni,et al. Mast Cell–Mediated Stimulation of Angiogenesis: Cooperative Interaction Between A2B and A3 Adenosine Receptors , 2003, Circulation research.
[3] D. Liem,et al. Sites of action of adenosine in interorgan preconditioning of the heart. , 2002, American journal of physiology. Heart and circulatory physiology.
[4] R. Sabina,et al. Regulation of skeletal muscle ATP catabolism by AMPD1 genotype during sprint exercise in asymptomatic subjects. , 2001, Journal of applied physiology.
[5] J. W. Rush,et al. Myoadenylate deaminase deficiency does not affect muscle anaplerosis during exhaustive exercise in humans , 2001, The Journal of physiology.
[6] B. Horne,et al. A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease. , 2000, Journal of the American College of Cardiology.
[7] M. Borger,et al. Optimal Myocardial Preconditioning in Humans a , 1999, Annals of the New York Academy of Sciences.
[8] T. Rebbeck,et al. Common variant in AMPD1 gene predicts improved clinical outcome in patients with heart failure. , 1999, Circulation.
[9] D. Yellon,et al. Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. , 1998, The American journal of physiology.
[10] R. Sabina,et al. Genetic and other determinants of AMP deaminase activity in healthy adult skeletal muscle. , 1998, Journal of applied physiology.
[11] E. Gabazza,et al. Adenosine regulates tissue factor expression on endothelial cells. , 1998, Thrombosis research.
[12] B. Groves,et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. , 1997, The Journal of clinical investigation.
[13] T. Morisaki,et al. Subunit composition of AMPD varies in response to changes in AMPD1 and AMPD3 gene expression in skeletal muscle. , 1996, Proceedings of the Association of American Physicians.
[14] M. Yacoub,et al. Nucleotide and adenosine metabolism in different cell types of human and rat heart. , 1994, Journal of molecular and cellular cardiology.
[15] M. Yacoub,et al. Liquid chromatographic evaluation of purine production in the donor human heart during transplantation. , 1993, Biomedical chromatography : BMC.
[16] E. Holmes,et al. Immunologic evidence for three isoforms of AMP deaminase (AMPD) in mature skeletal muscle. , 1993, Biochimica et biophysica acta.
[17] M. Le Hir,et al. Distribution and regulation of renal ecto-5'-nucleotidase: implications for physiological functions of adenosine. , 1993, The American journal of physiology.
[18] M. Hori,et al. Role of adenosine and its interaction with alpha adrenoceptor activity in ischaemic and reperfusion injury of the myocardium. , 1993, Cardiovascular research.
[19] T. Morisaki,et al. Molecular cloning of AMP deaminase isoform L. Sequence and bacterial expression of human AMPD2 cDNA. , 1992, The Journal of biological chemistry.
[20] R. Sabina,et al. Cloning of human AMP deaminase isoform E cDNAs. Evidence for a third AMPD gene exhibiting alternatively spliced 5'-exons. , 1992, The Journal of biological chemistry.
[21] T. Morisaki,et al. Molecular basis of AMP deaminase deficiency in skeletal muscle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] A. Nehlig,et al. Physiological and pharmacological properties of adenosine: therapeutic implications. , 1991, Life sciences.
[23] R. Smolenski,et al. Determination of sixteen nucleotides, nucleosides and bases using high-performance liquid chromatography and its application to the study of purine metabolism in hearts for transplantation. , 1990, Journal of chromatography.
[24] J. Schrader,et al. Turnover of adenosine in plasma of human and dog blood. , 1989, The American journal of physiology.
[25] R. Kelley,et al. Degradation and resynthesis of adenine nucleotides in adult rat heart myocytes. , 1987, The Journal of biological chemistry.
[26] S. Dimauro,et al. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. , 1984, The Journal of clinical investigation.
[27] T. Watanabe,et al. AMP deaminase isozymes in human tissues. , 1982, Biochimica et biophysica acta.
[28] E. Gelfand,et al. Distribution of 5'-nucleotidase in human lymphoid tissues. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Brooke,et al. Myoadenylate deaminase deficiency , 1979, Muscle & nerve.
[30] R. Berne. Cardiac nucleotides in hypoxia: possible role in regulation of coronary blood flow. , 1963, The American journal of physiology.